Shares of molecular-based technologies provider Applied DNA Sciences (APDN) gained 2.6% in Thursday’s extended trade after the company announced excellent year-over-year revenue growth for the fiscal third quarter ended June 30. The results, however, fell short of analysts' expectations. Applied DNA’s technologies protect supply chains, brands, products, and intellectual property of consumers, governments and companies from diversion, fraud, theft and counterfeiting. The company reported a loss of $0.46 per share, narrower than the year-ago loss of $0.72 per share but wider than the Street’s estimate of a loss of $0.22 per share. (See Applied DNA stock chart on TipRanks) Quarterly revenues soared 294% year-over-year to $1.
https://www.tipranks.com/news/applied-dnas-q3-results-miss-estimates-revenues-surge-294?utm_source=advfn.com&utm_medium=referral
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more Applied DNA Sciences Charts.
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more Applied DNA Sciences Charts.